Menopause Global Market Report 2024

The menopause market size has grown strongly in recent years. It will grow from $16.53 billion in 2023 to $17.74 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historical period can be attributed to factors such as the rising average life expectancy, increased awareness of women's health, the popularity of nutritional supplements, improvements in healthcare access, heightened focus on stress and lifestyle management, and the influence of patient advocacy efforts.

The menopause market size is expected to see strong growth in the next few years. It will grow to $22.64 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to an increased focus on cognitive health, the implementation of wellness programs in the workplace, the integration of mental health services, ongoing education and awareness campaigns, and the advancement of personalized medicine. Major trends in the forecast period include the development of digital health solutions for menopause, the exploration of non-hormonal therapies, research on long-term health outcomes, the widespread adoption of telemedicine and virtual health, and ongoing technological innovations in treatment approaches.

The escalating trend of physical inactivity among women is anticipated to drive the growth of the menopause market in the foreseeable future. Physical inactivity refers to minimal or absent engagement in physical activities encompassing leisure-time mobility, transportation, or occupational movement. The concerning rise in physical inactivity among menopausal women contributes to an increased demand for products and services aimed at managing menopausal symptoms, addressing associated health risks, and enhancing overall well-being. As per data reported by the Centers for Disease Control and Prevention in September 2023, the percentage of women reporting no physical activity surged by 7.9%, increasing from 213,555 in 2020 to 230,493 in 2021. Consequently, this trend of rising physical inactivity among women is a significant driver behind the growth of the menopause market.

The surge in lifestyle modifications is anticipated to propel the expansion of the menopause market in the coming years. Lifestyle changes involve shifts in individuals' choices and behaviors that impact their health and overall well-being. During the natural biological phase of menopause, making lifestyle adjustments can effectively manage menopausal symptoms and promote general health. Lifestyle modifications during menopause encompass adopting a healthy diet, regular exercise, adequate sleep, avoiding smoking and excessive alcohol consumption, and engaging in relaxing activities. For example, as reported by the Government Digital Service in January 2021, an extensive poll involving over 5,000 adults in England revealed that 80% of individuals aged 18 and above intended to modify their lifestyle choices. Hence, the escalating trend of lifestyle modifications stands as a driving force behind the growth of the menopause market.

The absence of adequate understanding poses a significant barrier to the development of targeted and effective treatments for menopausal symptoms. Women grappling with these symptoms often experience a notably diminished health-related quality of life (HRQoL) and heightened work impairment. The lack of comprehension and support can deter women from taking essential steps to manage these risks and sustain their overall well-being. For instance, research reported by the National Library of Medicine in June 2022 highlighted that 67% of women had insufficient awareness about menopause. Additionally, a survey conducted among 220 women in the UK unveiled a concerning lack of formal menopausal education. Consequently, this lack of understanding stands as a constraint hampering the growth potential of the menopause market.

Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.

In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.

Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc, The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC.

North America was the largest region in the menopause market in 2023. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.

The menopause market research report is one of a series of new reports that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 1-3 business days.